Vietnam Investment Review on MSN
XPOVIO approved in Hong Kong for multiple myeloma and lymphoma indications
Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or ...
GSK to present new data from its haematology portfolio at the 67th ASH Annual Meeting and Exposition
GSK plc will present new data from its haematology portfolio at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition (6 - 9 December), reinforcing its potential to redefine ...
XPOVIO® (selinexor) has received approvals for three indications in Hong Kong. These include its previous approval as the treatment for multiple myeloma ...
Study reveals that self-prescribed alternative medicines may worsen chronic kidney disease diagnosis in Telangana, impacting ...
CR in newly diagnosed NPM1-m AML, with 68% (17/25) of CRc responders achieving molecular MRD negativity by central NGS ...
- Inobrodib in combination with pomalidomide + dexamethasone (InoPd) demonstrates strong clinical efficacy and a tolerable safety profile in heavily pretreated relapsed/refractory multiple myeloma ...
Johnson & Johnson (NYSE:JNJ), the worldwide leader in multiple myeloma, today announced new data from the investigational Phase 3 MajesTEC-3 study that demonstrate the potential of TECVAYLI® ...
News-Medical.Net on MSN
Laughing gas shows fast antidepressant effects in early clinical trials
A systematic review and meta-analysis in eBioMedicine shows that nitrous oxide can rapidly reduce depressive symptoms within ...
Syndax Pharmaceuticals, Inc. ( SNDX) The 67th American Society of Hematology ( ASH) Annual Meeting December 8, 2025 7:00 AM EST ...
Although Hulu is traditionally an action haven for fans of the genre, the streamer didn’t add many new films in that category this month unless you really like the Planet of the Apes movies. But in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results